Compare China Regenerative Medicine International Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
HKD 111 Million ()
NA (Loss Making)
NA
0.00%
0.57
-409.54%
2.08
Revenue and Profits:
Net Sales:
71 Million
(Quarterly Results - Jul 2017)
Net Profit:
-68 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
35.19%
0%
35.19%
6 Months
-8.75%
0%
-8.75%
1 Year
82.5%
0%
82.5%
2 Years
-55.49%
0%
-55.49%
3 Years
-84.47%
0%
-84.47%
4 Years
-91.51%
0%
-91.51%
5 Years
-85.4%
0%
-85.4%
China Regenerative Medicine International Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
235.57%
EBIT Growth (5y)
-201.79%
EBIT to Interest (avg)
-30.61
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.09
Sales to Capital Employed (avg)
4.33
Tax Ratio
6.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.30
EV to EBIT
-0.65
EV to EBITDA
-0.88
EV to Capital Employed
1.86
EV to Sales
0.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-285.45%
ROE (Latest)
-753.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jul'17 - YoY
Jul'17
Jul'16
Change(%)
Net Sales
71.10
2.70
2,533.33%
Operating Profit (PBDIT) excl Other Income
-51.20
-72.10
28.99%
Interest
9.20
1.60
475.00%
Exceptional Items
0.80
0.00
Consolidate Net Profit
-68.00
-80.50
15.53%
Operating Profit Margin (Excl OI)
-920.60%
-31,297.40%
3,037.68%
USD in Million.
Net Sales
YoY Growth in quarter ended Jul 2017 is 2,533.33% vs 68.75% in Jul 2016
Consolidated Net Profit
YoY Growth in quarter ended Jul 2017 is 15.53% vs -73.49% in Jul 2016
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
72.10
90.60
-20.42%
Operating Profit (PBDIT) excl Other Income
8.30
29.40
-71.77%
Interest
1.20
1.10
9.09%
Exceptional Items
0.00
-17.30
100.00%
Consolidate Net Profit
27.50
17.80
54.49%
Operating Profit Margin (Excl OI)
-22.10%
203.30%
-22.54%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -20.42% vs 30.36% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 54.49% vs 116.53% in Dec 2024
About China Regenerative Medicine International Ltd. 
China Regenerative Medicine International Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






